Tilray
Latest news and updates related to tilray
About Tilray coverage
The Tilray news hub on Global Investing News tracks 9 recent headlines that matter to investors, policy watchers, and market strategists. Use this page to monitor how Tilray developments affect earnings expectations, sector rotation, supply chains, regulation, and cross-asset volatility. Stories are grouped by source type — market data, company announcements, regulatory filings, and expert analysis — so you can scan the signal quickly without wading through duplicate wire copy. When a headline links to a full article, you will find expanded context, key facts, and prediction-market angles where available. Bookmark this hub if you follow Tilray across quarters; new items are added as our crawl pipeline ingests fresh sources throughout the trading day.
Explore related topics
Latest Tilray headlines
Market Data
(3)Tilray CEO on Possible US Cannabis Reclassification
Tilray CEO on Possible US Cannabis Reclassification
Tilray and other cannabis stocks soar as Trump is reportedly ready to reclassify the substance
Tilray and other cannabis stocks soar as Trump is reportedly ready to reclassify the substance
Is Tilray Stock Going to $0?
Is Tilray Stock Going to $0?
Other Sources
(5)After Trump’s move to reclassify cannabis, here’s what Wall Street is thinking
This headline refers to former President Trump's administration's potential reclassification of cannabis under federal law. Such a move, likely from Schedule I to Schedule III under the Controlled Substances Act, would significantly reduce the regulatory burden on cannabis businesses, potentially opening up new avenues for banking, research, and corporate investment in the burgeoning industry.
Stock Market Today, Dec. 18: Tilray Brands Jumps After Trump Order Spurs Cannabis Rescheduling
Tilray Brands experienced a significant stock surge on December 18th following news that former President Trump has tasked officials with reviewing marijuana's scheduling. This development signals potential progress toward decriminalization or legalization at the federal level, which would open up new market opportunities for cannabis companies like Tilray.
Why Tilray Stock Soared 27.5% Today
Tilray (TLRY) shares surged today following an announcement that German lawmakers are moving forward with legislation to legalize cannabis for recreational adult use. This news is a significant positive for Tilray, as it has a substantial presence and market share in the German medical cannabis market and is well-positioned to capitalize on the expanded recreational market.
Stock Market Today, Dec. 16: Tilray Brands Surges 27.5% After Trump Signals Possible Marijuana Reclassification
Tilray Brands experienced a significant surge in its stock price, climbing 27.5%, following former President Donald Trump's remarks suggesting a potential reclassification of marijuana. This development hints at a more favorable regulatory environment for cannabis companies, which could lead to increased market access and reduced legal hurdles.
Tilray’s stock takes off on hope that cannabis will soon be treated more like steroids than heroin
Tilray's stock experienced a significant surge following reports that the Biden administration is considering reclassifying cannabis from a Schedule I drug, where it's grouped with substances like heroin, to a Schedule III drug, where it's treated more like steroids. This potential shift would drastically alter the regulatory landscape for cannabis, easing research restrictions and potentially opening up new avenues for banking and investment in the U.S.
Get alerts for this topic
Subscribe to receive updates about "Tilray"